Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Sun Pharmaceutical Industries Limited is an India-based specialty generic pharmaceutical company. The Company is engaged in the business of manufacturing, developing and marketing a wide range of ...

Explore list of mutual funds that have invested in Sun Pharma Advanced Research Com & analyse the ownership details to gain insights. HDFC Nifty Smallcap 250 Index Fund Regular Growth NA 0.16 0.08 ...

LOUISVILLE, Ky. (WAVE) - It’s an Alert Day as severe storms are possible in our area between 6 p.m. tonight and 5 a.m. Thursday. Damaging winds, marginally severe hail, and a small tornado threat are ...

LOUISVILLE, Ky. (WAVE) - Rounds of showers and thunderstorms will continue to rotate through the region throughout the morning into the afternoon. Overall, these storms will be scattered today, but ...

Those advocates still face one giant hurdle: FDA regulators say the treatment hasn’t been shown to work. In documents posted Monday, the FDA reiterated its longstanding position that drugmaker ...

Get ready for an alert on your cellphones, televisions and radios on Oct. 4. At 2:20 p.m, the federal government will test its nationwide Emergency Alert System and Wireless Emergency Alerts.

(RTTNews) - Sun Pharma Canada Inc., a wholly-owned subsidiary of Sun Pharmaceutical Industries Ltd (SUNPHARMA, 524715), Wednesday announced the launch of Winlevi, an androgen receptor inhibitor ...

NEXT Weather: Flood alerts at Central Jersey, Shore; worst of rain misses our region NEXT Weather: Flood alerts at Central Jersey, Shore; worst of rain misses our region 02:56 PHILADELPHIA (CBS ...

BALTIMORE -- Your umbrella can take a well deserved break today as we are looking rain free on this Orange Wednesday. We even have a little bit of sunshine to look forward to! Not a ton but some ...

Viatris Inc. (VTRS) and Ocuphire Pharma Inc. (OCUP) said Wednesday that the U.S. Food and Drug Administration has approved Ryzumvi to treat the side effects of pharmacologically-induced mydriasis ...